ClassID:

169307

G01N33/6812 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids; General methods of protein analysis not limited to specific proteins or families of proteins; Determination of free amino acids Assays for specific amino acids

Recent Application in this class:
#1
20260153512
2026-06-04

ESTIMATING GLOMERULAR FILTRATION RATES IN FELINES

#2
20260128170
2026-05-07

BIOMOLECULAR DETECTION METHOD AND DETECTION SYSTEM THEREOF

#3
20260035701
2026-02-05

METHODS AND COMPOSITIONS FOR TARGETING SERINE DEHYDRATASE

#4
20260002951
2026-01-01

METHOD FOR PROVIDING INFORMATION FOR BRAIN DOPING DIAGNOSIS

#5
20250369977
2025-12-04

Bio-Inspired Proline Sensors for Diagnosis and Surveillance of Stress in Living Systems

#6
20250314660
2025-10-09

METABOLIC BIOMARKERS FOR ASSESSING FRIEDREICH'S ATAXIA IN A SUBJECT

#7
20250306042
2025-10-02

METHOD FOR DIAGNOSING ENDOMETRIOSIS IN A SUBJECT

#8
20250271442
2025-08-28

Methods for Detecting Renal Disease

#9
20250208135
2025-06-26

Biomarkers for Neurodegenerative Disease

#10
20250147034
2025-05-08

Methods for Detecting Renal Disease

#11
20250147033
2025-05-08

ANALOGS AND CONJUGATES OF ß-AMINOISOBUTYRIC ACID (BAIB)

#12
20250147032
2025-05-08

METHOD FOR DETERMINING DEPRIVATION OF OUTER MEMBRANE OF CYANOBACTERIUM, APPARATUS FOR DETERMINING DEPRIVATION OF OUTER MEMBRANE OF CYANOBACTERIUM, AND PROGRAM

#13
20250130240
2025-04-24

MARKER AND DEVICE FOR DIAGNOSING OVERALL HEALTH STATUS OF INDIVIDUAL

#14
20250116672
2025-04-10

METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING TRYPTOPHAN AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF

#15
20250093361
2025-03-20

Method of evaluating lifestyle-related disease indicator, lifestyle-related disease indicator-evaluating apparatus, lifestyle-related disease indicator-evaluating method, lifestyle-related disease indicator-evaluating program product, lifestyle-related disease indicator-evaluating system, and information communication terminal apparatus

#16
20250093203
2025-03-20

HANDHELD BLOOD MEASURING DEVICE USING NANOPOROUS ANODIC ALUMINUM OXIDE SUBSTRATE AND APPLICATION OF SAME

#17
20250076303
2025-03-06

MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING

#18
20250051389
2025-02-13

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#19
20250027949
2025-01-23

EVALUATING METHOD FOR RELATIVE PHARMACOLOGICAL ACTIONS OF COMBINATIONS OF IMMUNE CHECKPOINT INHIBITORS AND ANTICANCER DRUGS AS COMBINATION DRUGS COMPARED WITH PHARMACOLOGICAL ACTIONS OF IMMUNE CHECKPOINT INHIBITORS ALONE, CALCULATING METHOD, EVALUATING APPARATUS, CALCULATING APPARATUS, EVALUATING PROGRAM, CALCULATING PROGRAM, RECORDING MEDIUM, EVALUATING SYSTEM, AND TERMINAL APPARATUS

#20
20250025442
2025-01-23

BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders

#21
20250020656
2025-01-16

EVALUATING METHOD, EVALUATING APPARATUS, EVALUATING PROGRAM PRODUCT, EVALUATING SYSTEM, AND TERMINAL APPARATUS

#22
20250020655
2025-01-16

METHOD FOR ANALYZING LEUCINE AND ISOLEUCINE, AS WELL AS DEVICE FOR ANALYZING LEUCINE AND ISOLEUCINE

#23
20250003940
2025-01-02

BIOSENSOR, BIOSENSOR COMPONENTS, AND USE THEREOF

#24
20250003930
2025-01-02

METHOD FOR ANALYZING AMINO ACIDS AND/OR ACYLCARNITINES

#25
20240418676
2024-12-19

ELECTROCHEMICAL SENSOR FOR DETECTING AND CHARACTERIZING A BIOLOGICAL MATERIAL

#26
20240410895
2024-12-12

METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING N-ACETYL-L-TRYPTOPHAN AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF

#27
20240402180
2024-12-05

METABOLITE BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PACREATIC CYSTS

#28
20240316223
2024-09-26

Oxidative Cyclization Reagents for Chemoselective Tryptophan Bioconjugation

#29
20240304331
2024-09-12

METHOD FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER, SYSTEM FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER

#30
20240248095
2024-07-25

METHOD FOR QUANTIFYING PHENYLALANINE IN BLOOD, AND MEASUREMENT KIT USED THEREFOR

#31
20240248081
2024-07-25

Homogenous Immunoassay with Compensation for Background Signal

#32
20240210423
2024-06-27

DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS ASSOCIATED WITH ALTERED METABOLIC PATHWAYS

#33
20240183862
2024-06-06

USE OF GLYCOPROTEIN ACETYLS FOR DETERMINING THE RISK OF DEVELOPING A GALLBLADDER DISORDER

#34
20240183711
2024-06-06

Handheld biomarker measuring device using nanoporous anodic aluminum oxide substrate and application of same

#35
20240118291
2024-04-11

DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS USING ALTERED RATIOS OF METABOLIC CONCENTRATIONS

#36
20240094216
2024-03-21

ODD CHAIN FATTY ACID THERAPY FOR THE TREATMENT OF MITOCHONDRIAL DISEASES

#37
20240085431
2024-03-14

METHODS FOR PROVIDING AND DETERMINING AN EFFICACIOUS WEIGHT LOSS DIET FOR A CANINE

#38
20240085411
2024-03-14

Genetically encoded biosensors

#39
20240069040
2024-02-29

DETECTION OF A RELAPSE IN A MULTIPLE SCLEROSIS PATIENT

#40
20240027466
2024-01-25

METHOD OF ISOLATING AND MEASURING DESMOSINE AND ISODESMOSINE IN ELASTIN

#41
20240019396
2024-01-18

Non-enzymatic electrochemical sensor for measuring analytes

#42
20230381182
2023-11-30

Biomarkers Related to Immune Checkpoint Inhibitor Therapy and Methods of Using the Same

#43
20230375561
2023-11-23

METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES

#44
20230366889
2023-11-16

METHODS OF DETECTING ISOASPARTIC ACID

#45
20230358609
2023-11-09

Gold nanoporous anodic aluminum oxide substrate of at-home blood phenylalanine measuring device for phenylketonuria and applications thereof

#46
20230349756
2023-11-02

Fabrication of gold nanoporous anodic aluminum oxide substrate of at-home blood phenylalanine measuring device for phenylketonuria

#47
20230348884
2023-11-02

Fluorescent Biosensor for Rapid Determination of L-arginine

#48
20230305016
2023-09-28

TEST KIT AND METHOD OF DETERMINING TRYPTOPHAN IN EXTRACTS OF FAECAL SAMPLES

#49
20230296617
2023-09-21

TRYPTOPHAN OPTICAL PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF

#50
20230296616
2023-09-21

ARGININE FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#51
20230287142
2023-09-14

HISTAMINE BINDING POLYPEPTIDES AND USES THEREOF

#52
20230251261
2023-08-10

METHOD OF DETECTING LUNG CANCER

#53
20230236204
2023-07-27

NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS

#54
20230221329
2023-07-13

Means and methods for single molecule peptide sequencing

#55
20230184779
2023-06-15

METHODS OF DETECTING CLOSTRIDIUM DIFFICILE INFECTIONS

#56
20230152310
2023-05-18

Single-chain polymer-based target receptors for use in electrochemical detection of target analytes

#57
20230145499
2023-05-11

Method for detecting l-serine based on cysteine desulfurase

#58
20230126856
2023-04-27

REAGENTS FOR RAPID CHIRAL LABELING AND ANALYSIS OF AMINE CONTAINING ENANTIOMERS

#59
20230102277
2023-03-30

DETECTION OF SYMMETRICAL DIMETHYLARGININE

#60
20230080158
2023-03-16

SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME

#61
20230058304
2023-02-23

AMINO ACID ANALYSIS METHOD

#62
20230057894
2023-02-23

At-home blood phenylalanine measuring device for phenylketonuria and applications thereof

#63
20230043193
2023-02-09

DIAGNOSTICS

#64
20230037869
2023-02-09

METHOD AND SYSTEM FOR ESTIMATING RENAL FUNCTION

#65
20230003714
2023-01-05

USE OF PAK4 AND CRTC1 FOR TREATMENT OR DIAGNOSIS OF BRAIN DEGENERATIVE DISEASE

#66
20220341952
2022-10-27

Methods and kits for the derivatization of a biogenic amine

#67
20220283154
2022-09-08

MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT

#68
20220283083
2022-09-08

Method for analyzing test substance, analyzer, training method, analyzer system, and analysis program

#69
20220276257
2022-09-01

Modular Chemical Probe For Detection Of Amino Acid Citrulline In Physiological Samples

#70
20220268782
2022-08-25

METHODS FOR PREDICTING AND TREATING CARDIAC DYSFUNCTION

#71
20220260582
2022-08-18

Peptide aptamer for specific recognition of arginine and its application

#72
20220257181
2022-08-18

MINIMALLY INVASIVE CONTINUOUS ANALYTE MONITORING FOR CLOSED-LOOP TREATMENT APPLICATIONS

#73
20220252620
2022-08-11

BLOOD INDICATORS OF ALZHEIMER'S DISEASE

#74
20220252610
2022-08-11

METHOD FOR ASSISTING EVALUATION OF CONDITION OF KIDNEYS, SYSTEM FOR EVALUATING CONDITION OF KIDNEYS, AND PROGRAM FOR EVALUATING CONDITION OF KIDNEYS

#75
20220221446
2022-07-14

Methods for Detecting Symmetrical Dimethylarginine

#76
20220221443
2022-07-14

BIOMARKER DETECTION FOR CANCER DIAGNOSIS AND PROGNOSIS

#77
20220221423
2022-07-14

AN ELECTROCHEMICAL SENSOR FOR DETECTING AND CHARACTERIZING A BIOLOGICAL MATERIAL

#78
20220218761
2022-07-14

MONITORING AND ALTERING THE GUT MICROBIOME IN DISEASE

#79
20220206016
2022-06-30

Examination method for dementia or risk thereof

#80
20220187303
2022-06-16

Method and composition for detection of proteolytic products and diagnosis of malignant neoplastic disease

#81
20220170945
2022-06-02

METHOD FOR ASSISTING EVALUATION OF RENAL PATHOLOGICAL CONDITIONS, SYSTEM FOR EVALUATING RENAL PATHOLOGICAL CONDITIONS AND PROGRAM FOR EVALUATING RENAL PATHOLOGICAL CONDITIONS

#82
20220137059
2022-05-05

Methods for Detecting Renal Disease

#83
20220091129
2022-03-24

REAGENTS AND METHODS FOR DETECTING PROTEIN LYSINE LACTYLATION

#84
20220050103
2022-02-17

Genetically encoded biosensors

#85
20220034893
2022-02-03

Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer

#86
20220034892
2022-02-03

Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer

#87
20220026438
2022-01-27

A LABELLING METHOD TO DISTINGUISH ISOBARIC AMINO ACIDS AND AMINO ACID COMBINATIONS

#88
20210382071
2021-12-09

BIOMARKERS FOR MITOCHONDRIAL DISEASES AND RELATED METHODS

#89
20210373031
2021-12-02

METHOD FOR DETERMINING GLOMERULAR FILTRATION ABILITY

#90
20210373030
2021-12-02

MARKER FOR DETERMING CRITICAL STAGE KIDNEY DISEASE

#91
20210364526
2021-11-25

Methods of selecting subjects for treatment with metabolomic modulators

#92
20210275486
2021-09-09

RENAL FUNCTION MAINTENANCE AND PROTECTION AGENT, AND METHOD FOR EVALUATING EFFECT THEREOF

#93
20210260057
2021-08-26

COMPOSITIONS AND METHODS TARGETING GLUTAMINE AND ITS METABOLISM FOR DIAGNOSING AND TREATING CANCER AND THERAPY-ASSOCIATED SIDE EFFECTS

#94
20210255193
2021-08-19

LYSINE REACTIVE PROBES AND USES THEREOF

#95
20210239704
2021-08-05

ANALOGS AND CONJUGATES OF BETA-AMINOISOBUTYRIC ACID (BAIB)

#96
20210215663
2021-07-15

APPARATUS FOR ANALYSIS OF EGGS

#97
20210190785
2021-06-24

Biomarkers for assessing breast cancer

#98
20210189487
2021-06-24

METHOD FOR SCREENING AGENTS PROMOTING SKIN BARRIER FUNCTION AND METHOD FOR EVALUATING SKIN BARRIER FUNCTION TAKING EPIDERMAL SERINE RACEMASE AND/OR D-SERINE LEVEL AS INDICATOR

#99
20210148911
2021-05-20

Methods and Diagnostics for Cancer Detection and Treatment Monitoring

#100
20210130402
2021-05-06

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#101
20210116460
2021-04-22

METHODS AND SYSTEMS FOR DETERMINING STATES OF MOLECULE FOLDING, CONFORMATION, OR INTERACTION AND APPLICATIONS FOR DETECTING PROTEOPATHIES

#102
20210115594
2021-04-22

VARIANT LIBRARIES OF THE IMMUNOLOGICAL SYNAPSE AND SYNTHESIS THEREOF

#103
20210072250
2021-03-11

Anti-hypusine antibodies and uses thereof

#104
20210055303
2021-02-25

Non-invasive analysis of embryo metabolites

#105
20210041467
2021-02-11

METHODS FOR ASSESSING THE NEED FOR AND THE EFFECTIVENESS OF THERAPY WITH ANTIOXIDANTS

#106
20210041424
2021-02-11

FORMULATIONS COMPRISING MERCURY-CONTAINING REAGENTS FOR DETECTING DISEASE

#107
20210018496
2021-01-21

Homogenous immunoassay with compensation for background signal

#108
20210003569
2021-01-07

Genetically encoded biosensors

#109
20200405678
2020-12-31

METHODS OF TREATING UREA CYCLE DISORDERS

#110
20200393402
2020-12-17

Single-chain polymer-based target receptors for use in electrochemical detection of target analytes

#111
20200386766
2020-12-10

METABOLIC SIGNATURES ASSOCIATED WITH DIAGNOSIS, DISEASE PROGRESSION, AND IMMUNOLOGICAL RESPONSE TO TREATMENT OF PATIENTS WITH COVID-19

#112
20200386765
2020-12-10

Method of examining diabetic complication

#113
20200371062
2020-11-26

NON-ENZYMATIC ELECTROCHEMICAL SENSOR FOR MEASURING ANALYTES

#114
20200352140
2020-11-12

Feeding management system and feeding management method

#115
20200283681
2020-09-10

Detection kit for quaternary ammonium compound having γ-carboxyl group

#116
20200271661
2020-08-27

High-throughput single molecule protein identification

#117
20200256846
2020-08-13

Levels, functions, and resistances related to chronic conditions by using lysine-based supplements

#118
20200247850
2020-08-06

Polypeptides for the treatment of diseases

#119
20200246465
2020-08-06

USE OF TRYPTOPHAN DERIVATIVES FOR PROTEIN FORMULATIONS

#120
20200240995
2020-07-30

KDAC VARIANTS AND USES THEREOF

#121
20200231956
2020-07-23

Means and methods for single molecule peptide sequencing

#122
20200200754
2020-06-25

Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer

#123
20200166519
2020-05-28

Mass spectrometry method for detection and quantitation of metabolites

#124
20200141956
2020-05-07

METHODS OF ASSESSING THE NEED FOR AND THE EFFECTIVENESS OF THERAPY WITH ANTIOXIDANTS

#125
20200116681
2020-04-16

Methods for detecting lacosamide by mass spectrometry

#126
20200064351
2020-02-27

POINT-OF-CARE DEVICE FOR THE QUANTITATIVE DETERMINATION OF BRANCHED-CHAIN AMINO ACIDS IN BIOLOGICAL SAMPLES

#127
20190391131
2019-12-26

BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE

#128
20190383819
2019-12-19

Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer

#129
20190376964
2019-12-12

Genetically encoded biosensors

#130
20190339282
2019-11-07

MARKER FOR EARLY DIAGNOSIS OF KIDNEY FAILURE

#131
20190339281
2019-11-07

MARKER FOR EARLY DIAGNOSIS OF KIDNEY FAILURE

#132
20190331678
2019-10-31

GENETICALLY ENCODED BIOSENSORS

#133
20190300953
2019-10-03

Method for screening agents promoting skin barrier function and method for evaluating skin barrier function taking epidermal serine racemase and/or D-serine level as indicator

#134
20190271705
2019-09-05

SH2 DOMAIN VARIANTS

#135
20190170776
2019-06-06

Methods and kits for the derivatization of a biogenic amine

#136
20190161515
2019-05-30

Materials and methods for detection and quantification of β-N-methylamino-L-alanine

#137
20190128872
2019-05-02

PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS

#138
20190120856
2019-04-25

Detection of symmetrical dimethylarginine

#139
20190106458
2019-04-11

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#140
20190094235
2019-03-28

Method for quantifying amino acid and amino acid quantification kit

#141
20190041385
2019-02-07

Methods for determining molecule folding associated with proteopathies

#142
20190017997
2019-01-17

USE OF PAK4 AND CRTC1 FOR TREATMENT OR DIAGNOSIS OF BRAIN DEGENERATIVE DISEASE

#143
20180372751
2018-12-27

LYSINE REACTIVE PROBES AND USES THEREOF

#144
20180372738
2018-12-27

Genetically encoded biosensors

#145
20180364249
2018-12-20

METHOD OF QUANTITATIVE DETERMINATION OF SARCOSINE IN A BIOLOGICAL SAMPLE

#146
20180356422
2018-12-13

Methods and Diagnostics for Cancer Detection and Treatment Monitoring

#147
20180335423
2018-11-22

Methods for Detecting Symmetrical Dimethylarginine

#148
20180328938
2018-11-15

Anti-hypusine antibodies and uses thereof

#149
20180321259
2018-11-08

Pathway specific markers for diagnosing irritable bowel syndrome

#150
20180299464
2018-10-18

Mass defect-based multiplex dimethyl pyrimidinyl ornithine (DiPyrO) tags for high-throughput quantitative proteomics and peptidomics

#151
20180284123
2018-10-04

BARCODED RAPID ASSAY PLATFORM USEFUL FOR EFFICIENT ANALYSIS OF CANDIDATE MOLECULES AND METHODS OF MAKING AND USING THE PLATFORM

#152
20180267018
2018-09-20

Biomarkers for Diagnosing Liver Disease

#153
20180263938
2018-09-20

METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS

#154
20180246116
2018-08-30

Methods of detecting and measuring glutamine and analogues thereof, and methods related thereto

#155
20180224407
2018-08-09

Methods for detecting lacosamide by mass spectrometry

#156
20180209972
2018-07-26

Genetically encoded biosensors

#157
20180188262
2018-07-05

Method for profiling protein methylation

#158
20180188254
2018-07-05

METHODS OF CHARACTERIZING ADRENOCORTICAL TUMORS

#159
20180180618
2018-06-28

Method of detecting lung cancer

#160
20180171509
2018-06-21

Variant libraries of the immunological synapse and synthesis thereof

#161
20180156816
2018-06-07

Immunoassays of s-adenosylmethionine and methylation index in personalized medicine and health evaluation

#162
20180144923
2018-05-24

METHOD FOR CHARACTERISING IONS

#163
20180136233
2018-05-17

PATHWAY SPECIFIC ASSAYS FOR PREDICTING IRRITABLE BOWEL SYNDROME DIAGNOSIS

#164
20180136232
2018-05-17

Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease

#165
20180128814
2018-05-10

Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomic ratios

#166
20180127801
2018-05-10

Analysis of amino acid copolymer compositions

#167
20180120326
2018-05-03

METHODS FOR DETECTING RENAL DISEASE

#168
20180113109
2018-04-26

Small molecule metabolites for the diagnosis of bacterial vaginosis and assessment of disease risk

#169
20180095091
2018-04-05

METHOD OF DIGITIZING NUTRITIONAL STATUS, MUSCLE TURNOVER, AND RISK ASSESSMENT

#170
20180088124
2018-03-29

Detection method for quaternary ammonium compound having γ-carboxyl group

#171
20180067137
2018-03-08

Compositions and methods for metabolic profiling in subjects with heart failure with preserved ejection fraction

#172
20180052177
2018-02-22

Method for the in vitro identification of drug-resistant epilepsy

#173
20180042897
2018-02-15

IPA as a protective agent

#174
20180031544
2018-02-01

Formulations comprising mercury-containing reagents for detecting disease

#175
20180028421
2018-02-01

Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population

#176
20180021292
2018-01-25

METHODS OF TREATING UREA CYCLE DISORDERS

#177
20180017570
2018-01-18

EVALUATING METHOD, EVALUATING APPARATUS, EVALUATING PROGRAM PRODUCT, EVALUATING SYSTEM, AND TERMINAL APPARATUS

#178
20180017553
2018-01-18

Genetically encoded biosensors

#179
20180015065
2018-01-18

METHODS OF TREATING UREA CYCLE DISORDERS

#180
20180015058
2018-01-18

METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS

#181
20170354632
2017-12-14

METHODS OF TREATING UREA CYCLE DISORDERS

#182
20170354631
2017-12-14

METHODS OF TREATING UREA CYCLE DISORDERS

#183
20170343557
2017-11-30

USE OF 5-METHOXYTRYPTOPHAN AS DIAGNOSTIC AGENT OF INFLAMMATORY DISEASES

#184
20170328915
2017-11-16

CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE

#185
20170307637
2017-10-26

Pathway specific markers for diagnosing irritable bowel syndrome

#186
20170299592
2017-10-19

Biomarkers for assessing breast cancer

#187
20170266143
2017-09-21

METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS

#188
20170239355
2017-08-24

USE OF TRYPTOPHAN DERIVATIVES FOR PROTEIN FORMULATIONS

#189
20170219521
2017-08-03

Non-enzymatic electrochemical sensor for measuring analytes

#190
20170218430
2017-08-03

DETECTION OF PROTEIN ARGININE DEMETHYLASE ACTIVITY

#191
20170198329
2017-07-13

DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF AMINOACIDOPATHIES

#192
20170184570
2017-06-29

Diagnostics

#193
20170160246
2017-06-08

Biomarkers for assessing HIV

#194
20170102368
2017-04-13

Methods for detecting lacosamide by mass spectrometry

#195
20170089902
2017-03-30

Methods and diagnostics for cancer detection and treatment monitoring

#196
20170073751
2017-03-16

Method for screening agents promoting skin barrier function and method for evaluating skin barrier function taking epidermal serine racemase and/or D-serine level as indicator

#197
20170016908
2017-01-19

BIOMARKERS FOR ASSESSING KIDNEY DISEASES

#198
20160377639
2016-12-29

METHODS FOR DETECTING, DIAGNOSING AND TREATING TRAUMATIC BRAIN INJURY

#199
20160376309
2016-12-29

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#200
20160375044
2016-12-29

Compositions and methods for inhibiting arginase activity

#201
20160370379
2016-12-22

BLOOD-BASED BIOMARKER FOR CANCER

#202
20160341748
2016-11-24

Methods of assessing the need for and the effectiveness of therapy with antioxidants

#203
20160341740
2016-11-24

Methods of diagnosing bipolar disorders and screening for therapeutic compounds

#204
20160327573
2016-11-10

Methods for Diagnosing Onset and Monitoring Progression of Huntington's Disease

#205
20160313342
2016-10-27

Marker for early diagnosis of kidney failure

#206
20160312264
2016-10-27

ANALYSIS OF AMINO ACID COPOLYMER COMPOSITIONS

#207
20160304886
2016-10-20

Compositions and method for destabilizing, altering, and dispersing biofilms

#208
20160299151
2016-10-13

Methods of detecting and measuring glutamine and analogues thereof, and methods related thereto

#209
20160245801
2016-08-25

Homogenous immunoassay with compensation for background signal

#210
20160202239
2016-07-14

Blood based biomarkers for diagnosing atherosclerotic coronary artery disease

#211
20160195547
2016-07-07

DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE

#212
20160187348
2016-06-30

Methods for detecting renal disease

#213
20160168613
2016-06-16

Device and methods of using device for detection of aminoacidopathies

#214
20160139148
2016-05-19

Pathway specific markers for diagnosing irritable bowel syndrome

#215
20160130329
2016-05-12

Compositions and methods related to recombinant antibodies to histone posttranslational modifications

#216
20160130279
2016-05-12

Pathway specific assays for predicting irritable bowel syndrome diagnosis

#217
20160122702
2016-05-05

Method for determining cell state and autoanalyzer using said method

#218
20160074356
2016-03-17

METHODS OF TREATING UREA CYCLE DISORDERS

#219
20160069892
2016-03-10

Analysis of amino acid copolymer compositions

#220
20160041154
2016-02-11

Immunoassays of S-adenosylmethionine and methylation index in personalized medicine and health evaluation

#221
20160018407
2016-01-21

METABOLIC PROFILES

#222
20160011203
2016-01-14

Hexanoylglycine as biomarker for the predisposition for weight gain and obesity

#223
20150376334
2015-12-31

Analysis of amino acid copolymer compositions

#224
20150355197
2015-12-10

Biomarkers for differentiating between non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD)

#225
20150301025
2015-10-22

PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS

#226
20150216845
2015-08-06

Indole lactic acid or a mixture of indole lactic acid and indole-3-propionic acid for treatment of Huntington's disease

#227
20150212093
2015-07-30

Labeled chiral alpha-hydroxy ketoacid derivatives, a process for preparing said derivatives and their use

#228
20150185238
2015-07-02

NOVEL METHOD FOR THE DIAGNOSIS OF ENDOMETRIOSIS

#229
20150177258
2015-06-25

SH2 domain variants

#230
20150160224
2015-06-11

QUANTITATION OF BIOMARKERS FOR THE DETECTION OF PROSTATE CANCER

#231
20150153353
2015-06-04

METHODS FOR DIAGNOSING CHRONIC VALVULAR DISEASE

#232
20150111222
2015-04-23

Genetically encoded biosensors

#233
20150105296
2015-04-16

HYDROXY-SPHINGOMYELIN 22:1 AS A BIOMARKER FOR HEALTHY AGING

#234
20150072043
2015-03-12

9-oxo-HODE as a biomarker for healthy aging

#235
20150056720
2015-02-26

Device and method for analyzing target

#236
20150053852
2015-02-26

Method for diagnosing stomach cancer using change of tryptophan metabolism

#237
20150044715
2015-02-12

Method for analyzing formyl glycine residue

#238
20150010936
2015-01-08

Modified leucine dehydrogenase

#239
20150004173
2015-01-01

Compositions and methods for analyzing histidine phosphorylation

#240
20140361160
2014-12-11

Methods for detecting lacosamide by mass spectrometry

#241
20140357524
2014-12-04

Method for quantifying amino acids with pyrophosphate

#242
20140332697
2014-11-13

Method of detecting thalassemia by optical analysis of blood components

#243
20140329271
2014-11-06

Media comprising a glutamine biosensor and methods of use thereof

#244
20140242723
2014-08-28

Methods for detecting symmetrical dimethylarginine

#245
20140186964
2014-07-03

Means and methods for assessing increased peroxisomal proliferation

#246
20140127724
2014-05-08

System and method for quantifying fragile X mental retardiation 1 protein in tissue and blood samples

#247
20140116118
2014-05-01

IPA as a therapeutic agent and a biomarker for disease risk for Huntington's disease

#248
20140113378
2014-04-24

Method of evaluating fatty liver related disease, fatty liver related disease-evaluating apparatus, fatty liver related disease-evaluating method, fatty liver related disease-evaluating program product, fatty liver related disease-evaluating system, information communication terminal apparatus, and method of searching for prophylactic/ameliorating substance for fatty liver related disease

#249
20140080140
2014-03-20

Screening for neurotoxic amino acid associated with neurological disorders

#250
20140065652
2014-03-06

Analysis of amino acid copolymer compositions

#251
20130306485
2013-11-21

Molecularly imprinted conducting polymer film based aqueous amino acid sensors

#252
20130281530
2013-10-24

Methods of therapeutic monitoring of phenylacetic acid prodrugs

#253
20130280740
2013-10-24

Methods for detecting symmetrical dimethylarginine

#254
20130267469
2013-10-10

IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk

#255
20130217036
2013-08-22

Diagnostic tools for charcot-marie-tooth disease

#256
20130143240
2013-06-06

Homoarginine as a biomarker for the risk of mortality

#257
20130126722
2013-05-23

Biomarkers for diagnosing liver disease

#258
20130109578
2013-05-02

Differentiation of isobaric amino acids and other species

#259
20130071863
2013-03-21

Sulfur-containing amino acid derivative

#260
20130059799
2013-03-07

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#261
20130040314
2013-02-14

IMMUNOASSAY OF CARBOXYMETHYLARGININE

#262
20130004972
2013-01-03

METHOD FOR THE DETECTION OF PREDIABETES

#263
20120295295
2012-11-22

DETECTING ISOMERS USING DIFFERENTIAL DERIVATIZATION MASS SPECTROMETRY

#264
20120202883
2012-08-09

EFFECTS OF IDH1 AND IDH2 MUTATIONS ON THE CELLULAR METABOLOME

#265
20120190586
2012-07-26

Synthetic Receptors for Identification of Protein Posttranslation Modifications

#266
20120156703
2012-06-21

Use of mimecan in the assessment of heart failure

#267
20120108668
2012-05-03

METABOLIC PROFILES

#268
20120094860
2012-04-19

Compositions, antibodies, asthma diagnosis methods, and methods for preparing antibodies

#269
20120045769
2012-02-23

Cellular assay employing detectable protein

#270
20120041684
2012-02-16

Method of evaluating obesity, obesity-evaluating apparatus, obesity-evaluating method, obesity-evaluating system, obesity-evaluating program product, recording medium, and information communication terminal apparatus

#271
20120022157
2012-01-26

DOSING AND MONITORING PATIENTS ON NITROGEN-SCAVENGING DRUGS

#272
20110282585
2011-11-17

Hepatic disease-evaluating apparatus, hepatic disease-evaluating method, hepatic disease-evaluating system, hepatic disease-evaluating program and recording medium

#273
20110257030
2011-10-20

Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population

#274
20110257020
2011-10-20

Biomarker-Based Methods For Formulating Compositions That Improve Skin Quality And Reduce The Visible Signs Of Aging In Skin

#275
20110256561
2011-10-20

LIVER DISEASE MARKER, METHOD AND APPARATUS FOR MEASURING THE SAME, AND METHOD FOR ASSAYING PHARMACEUTICAL PREPARATION

#276
20110253158
2011-10-20

Methods For Improving Skin Quality

#277
20110253157
2011-10-20

Methods For Improving Skin Quality

#278
20110251872
2011-10-13

Methods For Improving Skin Quality

#279
20110250141
2011-10-13

Methods For Improving Skin Quality

#280
20110247954
2011-10-13

Methods For Improving Skin Quality

#281
20110244504
2011-10-06

Biomarkers of inflammation in Bruch's membrane of the human retina

#282
20110244492
2011-10-06

Immunoassays for citrullinated proteins

#283
20110223624
2011-09-15

Immunoassay for detection of neurotoxic amino acid associated with neurological disorders

#284
20110201128
2011-08-18

BLOOD MARKERS OF TRANSPLANTED INTESTINE REJECTION

#285
20110189780
2011-08-04

Detecting leucine and its isomers using differential esterification mass spectrometry

#286
20110183424
2011-07-28

Screening for neurotoxic amino acid associated with neurological disorders

#287
20110165606
2011-07-07

METHODS FOR MODIFYING, ISOLATING, DETECTING, VISUALIZING, AND QUANTIFYING CITRULLINATED AND/OR HOMOCITRULLINATED PEPTIDES, POLYPEPTIDES AND PROTEINS

#288
20110144307
2011-06-16

Methods and compositions comprising non-natural amino acids

#289
20110138889
2011-06-16

Method of evaluating prostatic disease

#290
20110129933
2011-06-02

Means and methods for assessing increased peroxisomal proliferation

#291
20110104818
2011-05-05

Carbamylated proteins and risk of cardiovascular disease

#292
20110104719
2011-05-05

Methylarginine detection in cells and tissues

#293
20110097736
2011-04-28

Methods of determining levels of free amino acids and dipeptides and diagnosing Alzheimer's disease

#294
20110088457
2011-04-21

Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid

#295
20110079093
2011-04-07

Methods of distinguishing between glutamine formed by cataplerosis or proteolysis

#296
20110045002
2011-02-24

METHODS OF MODULATING IMMUNE RESPONSES BY MODULATING TIM-1, TIM-2 AND TIM-4 FUNCTION

#297
20110035156
2011-02-10

Method of evaluating gastric cancer, gastric cancer-evaluating apparatus, gastric cancer-evaluating method, gastric cancer-evaluating system, gastric cancer-evaluating program and recording medium

#298
20110015373
2011-01-20

Imprinted polymers with affinity for phosphorylated peptides and proteins

#299
20110003842
2011-01-06

Marker for determination of sensitivity to anti-cancer agent

#300
20100331266
2010-12-30

Analysis of amino acid copolymer compositions